期刊文献+

PTAR联合Child-Pugh及MELD评分对肝硬化患者发生慢加急性肝衰竭预测价值研究 被引量:15

Clinical significance of PTAR,Child-Pugh and MELD score in predicting the occurence of acute-on-chronic liver failure in patients with cirrhosis
下载PDF
导出
摘要 目的探讨影响乙肝肝硬化及酒精性肝硬化患者发生慢加急性肝衰竭(acute-on-chronic liver failure,ACLF)的危险因素,并建立新的评分模型预测ACLF的发生。方法纳入乙肝肝硬化患者148例,酒精性肝硬化患者113例。根据6个月内随访记录,将进展为ACLF者纳入ACLF组(24例),未进展为ACLF者纳入非ACLF组(237例)。收集患者临床资料,并计算凝血酶原国际标准化比值与血清白蛋白比值(PTAR)等评分。分析影响ACLF进展的独立危险因素后建立新的预测模型,并通过建立受试者工作特征曲线(ROC)评价新型模型对ACLF发生的预测价值。结果Child-Pugh及PTAR评分是影响乙肝肝硬化患者发展为ACLF的独立危险因素。PTAR及MELD评分是影响酒精性肝硬化患者发展为ACLF的独立危险因素。乙肝肝硬化中Child-Pugh、PTAR、PTAR-CP的曲线下面积(AUC)分别为0.691、0.755、0.805,PTAR-CP≥-3.93患者发生ACLF的风险高。酒精性肝硬化中MELD、PTAR、PTAR-MELD的AUC分别为0.715、0.744、0.773,PTAR-MELD≥-2.15患者发生ACLF的风险高。结论PTAR-CP对乙肝肝硬化进展为ACLF的预测价值更高,而PTAR-MELD对酒精性肝硬化进展为ACLF的预测价值更高。ABIC、ALBI对于肝硬化患者进展为ACLF的预测价值有限。 Objective To investigate the risk factors affecting the occurence of acute-on-chronic liver failure(ACLF)in patients with hepatitis B cirrhosis and alcoholic cirrhosis,and establish a new scoring model to predict the occurrence of ACLF.Methods 148 cases with hepatitis B cirrhosis and 113 cases with alcoholic cirrhosis were enrolled.According to the follow-up records within 6 months,they were divided into ACLF group(n=24)and non-ACLF group(n=237)according to whether they progress into ACLF.Clinical data of the first admission were collected,and the PTAR,ALBI,ABIC,Child-Pugh,MELD,MELD-Na scores were calculated.Multivariate Logistic regression analysis was used to analyze the independent risk factors affecting the development of ACLF,and a new prediction model was established.Area under the receiver operating characteristic curve was used to calculate the predicted value of the models with respect to the occurence of ACLF.Results In hepatitis B cirrhosis,Child-Pugh and PTAR scores were independent risk factors affecting the development of ACLF.PTAR and MELD scores were independent risk factors in alcoholic cirrhosis.In hepatitis B cirrhosis,the AUC of Child-Pugh,PTAR and PTAR-CP were 0.691,0.755 and 0.805,respectively.Patients with PTAR-CP≥-3.93 had a higher risk of ACLF than patients<-3.93.In alcoholic cirrhosis,the AUC of MELD,PTAR and PTAR-MELD was 0.715,0.744 and 0.773,respectively.Patients with PTAR-MELD≥-2.15 had a higher risk of ACLF than those<2.15.Conclusion PTAR-CP can predict the occurrence of ACLF in patients with hepatitis B cirrhosis more accurately.While the predictive value of PTAR-MELD is higher in alcoholic cirrhosis.ABIC and ALBI scores are of limited value in predicting the progression of ACLF in patients with cirrhosis.
作者 康宁 齐丽翠 袁岳 刘丽 白云 郑吉敏 崔子瑾 张建 王存凯 王玉珍 KANG Ning;QI Licui;YUAN Yue;LIU Li;BAI Yun;ZHENG Jimin;CUI Zijin;ZHANG Jian;WANG Cunkai;WANG Yuzhen(Graduate School of Hebei Medical University,Shijiazhuang 050000;Graduate School of Hebei North University;Department of Gastroenterology,Hebei General Hospital,China)
出处 《胃肠病学和肝病学杂志》 CAS 2020年第10期1171-1178,共8页 Chinese Journal of Gastroenterology and Hepatology
基金 河北省2019年度医学科学研究课题(20190260)。
关键词 肝硬化 慢加急性肝衰竭 PTAR评分 CHILD-PUGH评分 MELD评分 Cirrhosis Acute-on-chronic liver failure PTAR score Child-Pugh score MELD score
  • 相关文献

参考文献5

二级参考文献81

  • 1Richa Bhardwaj,Haleh Vaziri,Arun Gautam,Enrique Ballesteros,David Karimeddini,George Y. Wu.Chylous Ascites:A Review of Pathogenesis,Diagnosis and Treatment[J].Journal of Clinical and Translational Hepatology,2018,6(1):105-113. 被引量:38
  • 2饶慧瑛,郭芳,魏来.2005年美国肝病学会急性肝衰竭诊治和肝移植患者评价指南简介[J].中华肝脏病杂志,2006,14(2):154-156. 被引量:23
  • 3Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:830
  • 4Richard Moreau,Rajiv Jalan,Pere Gines,Marco Pavesi,Paolo Angeli,Juan Cordoba,Francois Durand,Thierry Gustot,Faouzi Saliba,Marco Domenicali,Alexander Gerbes,Julia Wendon,Carlo Alessandria,Wim Laleman,Stefan Zeuzem,Jonel Trebicka,Mauro Bernardi,Vicente Arroyo.Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis[J]. Gastroenterology . 2013 (7)
  • 5Shaoli You,Yihui Rong,Bing Zhu,Aimin Zhang,Hong Zang,Hongling Liu,Dongze Li,Zhihong Wan,Shaojie Xin.Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey[J]. Hepatology International . 2013 (2)
  • 6Rajiv Jalan,Pere Gines,Jody C Olson,Rajeshwar P Mookerjee,Richard Moreau,Guadalupe Garcia-Tsao,Vicente Arroyo,Patrick S Kamath.Acute-on chronic liver failure[J]. Journal of Hepatology . 2012 (6)
  • 7Michael G. Shlipak,Steven G. Coca,Zhu Wang,Prasad Devarajan,Jay L. Koyner,Uptal D. Patel,Heather Thiessen-Philbrook,Amit X. Garg,Chirag R. Parikh.Presurgical Serum Cystatin C and Risk of Acute Kidney Injury After Cardiac Surgery[J]. American Journal of Kidney Diseases . 2011 (3)
  • 8Shiv Kumar Sarin,Ashish Kumar,John A. Almeida,Yogesh Kumar Chawla,Sheung Tat Fan,Hitendra Garg,H. Janaka Silva,Saeed Sadiq Hamid,Rajiv Jalan,Piyawat Komolmit,George K. Lau,Qing Liu,Kaushal Madan,Rosmawati Mohamed,Qin Ning,Salimur Rahman,Archana Rastogi,Stephen M. Riordan,Puja Sakhuja,Didier Samuel,Samir Shah,Barjesh Chander Sharma,Praveen Sharma,Yasuhiro Takikawa,Babu Ram Thapa,Chun-Tao Wai,Man-Fung Yuen.Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)[J]. Hepatology International . 2009 (1)
  • 9E.CHOLONGITAS,V.SHUSANG,L.MARELLI,D.NAIR,M.THOMAS,D.PATCH,A.BURNS,P.SWENY,A. K.BURROUGHS.Review article: renal function assessment in cirrhosis – difficulties and alternative measurements[J]. Alimentary Pharmacology & Therapeutics . 2007 (7)
  • 10P. Sj?str?m,M. Tidman,I. Jones.Determination of the production rate and non‐renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans[J]. Scandinavian Journal of Clinical & Laboratory Investigation . 2005 (2)

共引文献1410

同被引文献169

引证文献15

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部